CompletedNCT02557984
Dopamine and Opioid Blockers in Reward and Impulse-Control Tasks
About this title
Read the official source — NCT02557984Medication studyAges 18–35SwitzerlandAddiction
Understand this study
Who was this study for?
This study was for healthy volunteers. Listed age limits: 18 years to 35 years. Other eligibility criteria applied.
- Listed locations
- ZurichSee all locations and recruitment
Study information
Study start dateFebruary 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 121
- Sponsor
- University of Zurich
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Switzerland
- Age range
- From 18 Years to 35 Years
- Official registry ID
- NCT02557984
- Official title
Show the full official title
Dopamine D2/3- and μ-opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity in Healthy Volunteers
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Zurich
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Zurich, a university.
Did this study involve medication?
Yes. The study involved medication, including Placebo, Amisulpride and Naltrexone.
Who was this study for?
This study was for healthy volunteers. Listed age limits: 18 years to 35 years. Other eligibility criteria applied.
